S. 2503
IntroducedPreventing Superbugs and Protecting Patients Act
Latest Action
Placed on Senate Legislative Calendar under General Orders. Calendar No. 417.
4/5/2016 • Senate
Summary
Preventing Superbugs and Protecting Patients Act
(Sec. 2) This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to identify types of medical devices for which premarket notification must include proposed labeling, including validated instructions regarding cleaning, disinfection, and sterilization.
(Sec. 3) The FDA must issue final guidance regarding when a premarket notification is required for a modification to a medical device.Reported to Senate with amendment(s) • 4/5/2016
Topics & Subjects
CBO Cost Estimates (1)
Congressional Votes (0)
No recorded votes yet
Roll call votes will appear here as the bill moves through Congress
Related Federal Spending
Sponsor & Cosponsors (1)
Sponsor
No cosponsors yet
Cosponsors may be added as the bill moves through Congress
Bill Journey
Originated in the Senate
Introduced
February 4, 2016
Committee Review
February 9, 2016
Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
Floor Debate
Passed Chamber
Other Chamber
President
Enacted into Law